Young Ju Noh
Overview
Explore the profile of Young Ju Noh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kwon J, Yang S, Koh S, Noh Y, Kang D, Yang S, et al.
Cancer Res Treat
. 2024 Apr;
56(4):1040-1049.
PMID: 38605663
Purpose: A "Smart Cancer Care" platform that integrates patient-reported outcomes (PROs) with management has been established in Korea. This study focused on improving health behaviors and connecting patients to welfare...
2.
Seo M, Ko B, Tae S, Koh S, Noh Y, Choi H, et al.
Nucl Med Commun
. 2016 Sep;
37(12):1318-1324.
PMID: 27636120
Aim: Although rib uptake is frequently detected in follow-up bone scans of breast cancer patients, few studies have assessed its clinical significance. Patients And Methods: Among 1208 breast cancer patients...
3.
Kim Y, Ahn S, Choi E, Kim J, Lee S, Noh Y, et al.
Cancer Res Treat
. 2015 Dec;
34(6):450-6.
PMID: 26680904
Purpose: We evaluated the patterns of failure, survival rate, prognostic factors and treatment related complication in postoperative radiation treatment of patients with ependymoma. Materials And Methods: We retrospectively analyzed 25...
4.
Lee S, Choi E, Oh S, Suh C, Kim S, Lee J, et al.
Cancer Res Treat
. 2015 Dec;
34(5):345-51.
PMID: 26680886
Purpose: To investigate the feasibility, toxicity and response rate, of concurrent chemoradiation therapy with paclitaxel/cisplatin in stage III locally advanced non-small cell lung cancer (NSCLC). Materials And Methods: Between May...
5.
Baek J, Kim H, Ahn J, Jegal Y, Seo K, Ra S, et al.
Lung Cancer
. 2011 Dec;
76(3):368-72.
PMID: 22192919
Background: The standard regimen in elderly patients with non-small-cell lung cancer (NSCLC) is still uncertain. Gemcitabine is one of the most widely used drugs for the treatment of NSCLC, and...
6.
Noh Y, Choi W, Kim J, Kim J, Yu C, Kim H, et al.
Cancer Res Treat
. 2009 Sep;
38(1):30-4.
PMID: 19771256
Purpose: Capecitabine is an oral fluoropyrimidine carbamate and it is known as an effective radiosensitizer. Capecitabine and its metabolite reach their peak concentration in the plasma at 1 approximately 2...
7.
Shin S, Kim H, Baek J, Ahn J, Jegal Y, Seo K, et al.
Lung Cancer
. 2007 Nov;
60(1):83-91.
PMID: 18006180
Purpose: The standard chemotherapy for non-elderly patients with advanced non-small-cell lung cancer (NSCLC) is platinum-based doublet combination therapy. Preclinical and clinical evidence indicates that infusion at the fixed dose rate...
8.
Min Y, Ahn J, Noh Y, Cha H, Suh J, Jung J, et al.
Korean J Intern Med
. 2004 Sep;
19(2):109-13.
PMID: 15366642
Background: The aim of this study was to evaluate the response, survival, and toxicities of a less intensive combination of paclitaxel and carboplatin, which is used in advanced non-small cell...
9.
Lee S, Choi E, Lee J, Lee S, Suh C, Kim S, et al.
Int J Radiat Oncol Biol Phys
. 2003 Jun;
56(4):996-1004.
PMID: 12829135
Purpose: To evaluate the feasibility, treatment outcome, and toxicity of hyperfractionated three-dimensional conformal radiotherapy (CRT) and concurrent mitomycin-C, vinblastine, and cisplatin (MVP) chemotherapy in locally advanced, unresectable, Stage III non-small-cell...